Company intelligence / Profile preview

Chongqing Yuyan Pharmaceutical

Chongqing, Chongqing, China

Ownership: Private
Development stage: Other

Overview

Chongqing Yuyan Pharmaceutical is a clinical-stage biopharmaceutical company based in Chongqing, China, specializing in the discovery and development of innovative small molecule therapeutics. The company primarily focuses on oncology, with a specific emphasis on targeting the fibroblast growth factor receptor (FGFR) pathway and KRAS mutations. Its lead programs include highly selective FGFR4 inhibitors designed to treat hepatocellular carcinoma and other solid tumors. Yuyan Pharmaceutical leverages its internal R&D capabilities to advance a pipeline of precision medicines aimed at addressing significant unmet medical needs in the Chinese and global markets.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Chongqing Yuyan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chongqing Yuyan Pharmaceutical.

Explore the full profile